{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:50:09Z","timestamp":1788792609931,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.vaccine.2005.07.064","type":"journal-article","created":{"date-parts":[[2005,8,9]],"date-time":"2005-08-09T11:30:18Z","timestamp":1123587018000},"page":"206-214","source":"Crossref","is-referenced-by-count":36,"title":["Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant"],"prefix":"10.1016","volume":"24","author":[{"given":"Gretel","family":"Sardi\u00f1as","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Reddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Pajon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gorringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.07.064_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0264-410X(92)90021-B","article-title":"The mucosal immune system: from fundamental concepts to vaccine development","volume":"10","author":"McGhee","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.14.2.430-445.2001","article-title":"Vaccination strategies for mucosal immune responses","volume":"14","author":"Ogra","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2005.07.064_bib3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0264-410X(02)00579-0","article-title":"Experience with registered mucosal vaccines","volume":"21","author":"Dietrich","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib4","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","article-title":"Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants","volume":"19","author":"Pizza","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.07.064_bib6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.064_bib7","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2005.07.064_bib8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.064_bib9","first-page":"127","article-title":"Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant","volume":"92","author":"Haneberg","year":"1998","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2005.07.064_bib10","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/S0264-410X(99)00046-8","article-title":"Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice","volume":"17","author":"Dalseg","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib11","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1128\/IAI.69.8.5010-5015.2001","article-title":"Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance","volume":"69","author":"Bakke","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.064_bib12","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.vaccine.2003.11.040","article-title":"Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memory","volume":"22","author":"Bakke","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib13","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/IAI.72.5.2528-2537.2004","article-title":"Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis","volume":"72","author":"Guthrie","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.064_bib14","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/IAI.66.4.1334-1341.1998","article-title":"Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans","volume":"66","author":"Haneberg","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.064_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0264-410X(99)00216-9","article-title":"Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers","volume":"18","author":"Drabick","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/IAI.67.2.921-927.1999","article-title":"Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine","volume":"67","author":"Oftung","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.064_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.70.2.702-707.2002","article-title":"Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine","volume":"70","author":"Katial","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.064_bib18","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0264-410X(02)00774-0","article-title":"Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease","volume":"21","author":"Aase","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0264-410X(99)00219-4","article-title":"Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP)","volume":"18","author":"Estevez","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib20","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/IAI.70.7.3621-3626.2002","article-title":"Neisseria lactamica protects against experimental meningococcal infection","volume":"70","author":"Oliver","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.064_bib21","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/S0264-410X(01)00077-9","article-title":"Evaluation of cross-reactive antigens as determinants of cross-bactericidal activity in pathogenic and commensal Neisseria","volume":"19","author":"Sanchez","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib22","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1016\/S0264-410X(02)00224-4","article-title":"In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica","volume":"20","author":"Sanchez","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib23","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1128\/IAI.72.11.6511-6518.2004","article-title":"Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential","volume":"72","author":"O\u2019dwyer","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.064_bib24","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0168-8278(03)00152-1","article-title":"Hepatitis B vaccines","volume":"39","author":"Shouval","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2005.07.064_bib25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0264-410X(96)00062-X","article-title":"Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination","volume":"11","author":"West","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-1656(99)00201-1","article-title":"Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris","volume":"77","author":"Hardy","year":"2000","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2005.07.064_bib27","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0264-410X(00)00348-0","article-title":"Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant","volume":"19","author":"Isaka","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib28","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/S0264-410X(02)00191-3","article-title":"Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses","volume":"20","author":"Debin","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1574-695X.2002.tb00551.x","article-title":"Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA","volume":"32","author":"McCluskie","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.064_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/mpat.1993.1085","article-title":"Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model","volume":"15","author":"Mackinnon","year":"1993","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2005.07.064_bib31","series-title":"Methods in molecular medicine, vol 66. Meningococcal vaccines: methods and protocols","first-page":"81","article-title":"Outer membrane protein vesicle vaccines for meningococcal disease","author":"Frasch","year":"2001"},{"key":"10.1016\/j.vaccine.2005.07.064_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2005.07.064_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0882-4010(88)90070-8","article-title":"Experimental meningococcal meningitis in the infant rat","volume":"4","author":"Saukkonen","year":"1988","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2005.07.064_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/mpat.2000.0419","article-title":"Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7, 16 subtype variants in an infant rat infection model","volume":"30","author":"Toropainen","year":"2001","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2005.07.064_bib35","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.vaccine.2005.01.053","article-title":"Experimental disease models for the assessment of meningococcal vaccines","volume":"23","author":"Gorringe","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib36","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/S0264-410X(99)00044-4","article-title":"Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins","volume":"17","author":"Cartwright","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/infdis\/137.2.112","article-title":"Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children","volume":"137","author":"Gold","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.064_bib38","series-title":"Meningococcal disease","first-page":"35","article-title":"Mechanisms of host immunity","author":"Griffiss","year":"1995"},{"key":"10.1016\/j.vaccine.2005.07.064_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-1119(97)00018-8","article-title":"The pilus colonization factor of pathogenic neisserial species: organelle biogenesis and structure\/function relationships\u2014a review","volume":"192","author":"Tonjum","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2005.07.064_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.molmed.2004.07.002","article-title":"CD46 in Neisseria pathogenesis","volume":"10","author":"Gill","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.vaccine.2005.07.064_bib41","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/00365540310016042","article-title":"Neisserial Opa proteins: impact on colonization, dissemination and immunity","volume":"35","author":"Gray-Owen","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.064_bib42","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1046\/j.1365-2958.1999.01411.x","article-title":"Iron acquisition systems in the pathogenic Neisseria","volume":"32","author":"Schryvers","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.064_bib43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1086476","article-title":"CD46 in meningococcal disease","volume":"301","author":"Johansson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.07.064_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0264-410X(98)00163-7","article-title":"For discussion: live attenuated vaccines for group B meningococcus","author":"Tang","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ije\/29.1.180","article-title":"Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica","volume":"29","author":"Coen","year":"2000","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2005.07.064_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1570162043485004","article-title":"Mucosal HIV vaccines: where are we now?","volume":"2","author":"Stevceva","year":"2004","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.vaccine.2005.07.064_bib47","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2005.07.064_bib48","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.vaccine.2004.07.049","article-title":"Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery","volume":"23","author":"Rodriguez","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib49","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1016\/j.vaccine.2004.02.010","article-title":"Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation","volume":"22","author":"Mesa","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.064_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/14760584.3.1.77","article-title":"Serologic correlates of protection for evaluating the response to meningococcal vaccines","volume":"3","author":"Balmer","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2005.07.064_bib51","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/IAI.69.3.1561-1567.2001","article-title":"Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection","volume":"69","author":"West","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.064_bib52","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T19:56:38Z","timestamp":1586375798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05007371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0264410X05007371"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}